VIRIDIAN THERAPEUTICS INC. - COMMON STOCK
16.40
14-فبراير-25 16:45:00
15 متأخرة بدقائق
الأسهم
-0.62
-3.64%
نطاق اليوم
16.38 - 17.25
ISIN
N/A
المصدر
NASDAQ
-
Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
11 أغسطس 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in the Wedbush PacGrow Healthcare Virtual Conference
05 أغسطس 2021 08:30:00 بحسب Nasdaq GlobeNewswire
-
Viridian Therapeutics Appoints Kristian Humer as Chief Financial Officer and Chief Business Officer
26 يوليو 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
15 يوليو 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
14 يوليو 2021 08:00:01 بحسب Nasdaq GlobeNewswire
-
Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference
07 يوليو 2021 08:00:01 بحسب Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in the JMP Securities Life Sciences Conference
10 يونيو 2021 08:00:01 بحسب Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in Upcoming Investor Conferences
14 مايو 2021 08:00:00 بحسب Nasdaq GlobeNewswire
-
Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
06 مايو 2021 16:05:01 بحسب Nasdaq GlobeNewswire
-
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
25 مارس 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
09 مارس 2021 16:30:00 بحسب Nasdaq GlobeNewswire